EG19361A - A process for the preparation of piperidine compound having local anaesthetica and analgetic - Google Patents

A process for the preparation of piperidine compound having local anaesthetica and analgetic

Info

Publication number
EG19361A
EG19361A EG74690A EG74690A EG19361A EG 19361 A EG19361 A EG 19361A EG 74690 A EG74690 A EG 74690A EG 74690 A EG74690 A EG 74690A EG 19361 A EG19361 A EG 19361A
Authority
EG
Egypt
Prior art keywords
anaesthetica
local
preparation
analgetic
piperidine compound
Prior art date
Application number
EG74690A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG19361A publication Critical patent/EG19361A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
EG74690A 1989-12-21 1990-12-20 A process for the preparation of piperidine compound having local anaesthetica and analgetic EG19361A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904298A SE8904298D0 (sv) 1989-12-21 1989-12-21 New compounds

Publications (1)

Publication Number Publication Date
EG19361A true EG19361A (en) 1994-12-30

Family

ID=20377821

Family Applications (1)

Application Number Title Priority Date Filing Date
EG74690A EG19361A (en) 1989-12-21 1990-12-20 A process for the preparation of piperidine compound having local anaesthetica and analgetic

Country Status (40)

Country Link
US (2) US5227389A (no)
EP (1) EP0506778B1 (no)
JP (1) JP2656152B2 (no)
KR (1) KR0179382B1 (no)
CN (1) CN1037841C (no)
AT (1) ATE138650T1 (no)
AU (1) AU647068B2 (no)
BG (1) BG60912B1 (no)
BR (1) BR1100379A (no)
CA (1) CA2069608C (no)
CZ (1) CZ278035B6 (no)
DE (1) DE69027221T2 (no)
DK (1) DK0506778T3 (no)
DZ (1) DZ1468A1 (no)
EG (1) EG19361A (no)
ES (1) ES2087280T3 (no)
FI (1) FI100881B (no)
HK (1) HK22997A (no)
HR (1) HRP920591B1 (no)
HU (1) HU213110B (no)
IE (1) IE74855B1 (no)
IL (1) IL96636A (no)
IS (1) IS1664B (no)
LT (1) LT4005B (no)
LV (2) LV10949B (no)
NO (1) NO178858C (no)
NZ (1) NZ236293A (no)
PL (1) PL163591B1 (no)
PT (1) PT96303B (no)
RO (1) RO112864B1 (no)
RU (1) RU2039043C1 (no)
SA (1) SA91110209B1 (no)
SE (1) SE8904298D0 (no)
SG (1) SG46413A1 (no)
SI (1) SI9012346B (no)
SK (1) SK658190A3 (no)
UA (1) UA26403A (no)
WO (1) WO1991009845A1 (no)
YU (1) YU48086B (no)
ZA (1) ZA909903B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3916092B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬
SE9400447D0 (sv) * 1994-02-11 1994-02-11 Astra Ab New compounds
SE9404438D0 (sv) * 1994-12-21 1994-12-21 Astra Ab New process
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
AR035234A1 (es) * 2001-04-12 2004-05-05 Pharmacopeia Drug Discovery Aril y biaril-piperidinas con actividad moduladora mch, metodo para preparar dichos compuestos, composiciones farmaceuticas, metodo para preparar las composiciones farmaceuticas y el uso de dichos compuestos para la manufactura de un medicamento
MXPA05006354A (es) * 2002-12-13 2005-08-26 Smithkline Beecham Corp Antagonistas ccr5 como agentes terapeuticos.
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
JP2011506466A (ja) 2007-12-11 2011-03-03 株式会社サイトパスファインダー カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
EP3914246A1 (en) 2019-01-22 2021-12-01 ICM (Institut du Cerveau et de la Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE96980C1 (no)
US2486796A (en) * 1943-06-25 1949-11-01 Ciba Pharm Prod Inc Esters of 1-alkyl-4-hydroxyphenylpiperidyl-4-ketones
US3334106A (en) * 1964-10-20 1967-08-01 Aldrich Chem Co Inc N(aryl)n(hydrocarbyl)-omega-(4-phenyl-4-piperidinocarbonylheteroamine) alkanoamide
US3539580A (en) * 1967-06-26 1970-11-10 Janssen Pharm 4-aryl-4-aminoalkoxy-piperidines
CH501622A (de) * 1968-12-20 1971-01-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Piperidinderivaten
US3737538A (en) * 1968-12-30 1973-06-05 Ciba Geigy Corp Antitussive compositions and method with isonipecotic acid derivatives
FR2156470A2 (en) * 1971-10-21 1973-06-01 Synthelabo 1-(3,3-diphenyl-1-propyl)-4-aryl-piperidines - as analgesics spasmolytic and anti-tussive agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
US5100903A (en) * 1989-05-12 1992-03-31 Anaquest, Inc. N-aryl-n-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds

Also Published As

Publication number Publication date
DZ1468A1 (fr) 2004-09-13
IL96636A0 (en) 1991-09-16
HU213110B (en) 1997-02-28
JPH05502869A (ja) 1993-05-20
HU9202044D0 (en) 1992-09-28
NO178858C (no) 1996-06-19
DK0506778T3 (da) 1996-10-07
LV10949A (lv) 1995-12-20
JP2656152B2 (ja) 1997-09-24
SE8904298D0 (sv) 1989-12-21
HRP920591B1 (en) 1998-12-31
US5227389A (en) 1993-07-13
FI922806A (fi) 1992-06-17
BG60912B1 (bg) 1996-06-28
WO1991009845A1 (en) 1991-07-11
US5360805A (en) 1994-11-01
ZA909903B (en) 1991-08-28
CZ658190A3 (en) 1993-01-13
SA91110209B1 (ar) 2004-05-08
AU6978391A (en) 1991-07-24
IE904534A1 (en) 1991-07-03
NZ236293A (en) 1992-10-28
CA2069608A1 (en) 1991-06-22
FI100881B (fi) 1998-03-13
SI9012346A (sl) 1998-08-31
LV5766B4 (lv) 1997-06-20
HK22997A (en) 1997-02-27
KR0179382B1 (ko) 1999-03-20
FI922806A0 (fi) 1992-06-17
RU2039043C1 (ru) 1995-07-09
YU48086B (sh) 1997-01-08
IS3659A7 (is) 1991-06-22
NO178858B (no) 1996-03-11
HRP920591A2 (en) 1997-08-31
ES2087280T3 (es) 1996-07-16
SG46413A1 (en) 1998-02-20
CN1053605A (zh) 1991-08-07
AU647068B2 (en) 1994-03-17
NO922380L (no) 1992-06-17
LV10949B (en) 1996-06-20
CA2069608C (en) 2001-07-10
IE74855B1 (en) 1997-08-13
EP0506778B1 (en) 1996-05-29
SK278283B6 (en) 1996-08-07
RO112864B1 (ro) 1998-01-30
LTIP1731A (en) 1995-07-25
NO922380D0 (no) 1992-06-17
PL163591B1 (pl) 1994-04-29
CZ278035B6 (en) 1993-07-14
BR1100379A (pt) 1999-12-07
PT96303A (pt) 1991-09-30
IL96636A (en) 1994-11-28
LV5766A4 (lv) 1996-12-20
PL288409A1 (en) 1991-12-02
KR927003531A (ko) 1992-12-18
DE69027221D1 (de) 1996-07-04
HUT64518A (en) 1994-01-28
SK658190A3 (en) 1996-08-07
ATE138650T1 (de) 1996-06-15
DE69027221T2 (de) 1996-10-10
UA26403A (uk) 1999-08-30
SI9012346B (sl) 1999-08-31
PT96303B (pt) 1998-07-31
EP0506778A1 (en) 1992-10-07
YU234690A (sh) 1993-10-20
CN1037841C (zh) 1998-03-25
IS1664B (is) 1997-07-04
LT4005B (en) 1996-07-25

Similar Documents

Publication Publication Date Title
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
CA2080249A1 (en) Preparation of substituted piperidines
ES8800679A1 (es) Un procedimiento para preparar derivados de piperiliden-dihidrodibenzo-(a,d)-cicloheptenos y derivados aza
AU582235B2 (en) Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
FI932388A (fi) 8-en-19,11b-bryggsteroider, deras framstaellning och farmaceutiska preparat innehaollande dem
RU2091378C1 (en) 7-acyl-3-substituted carbamoylhydroxycephems, methods of their synthesis, substituted carbamoylhydroxy-3-cephems, methods of their synthesis and antibacterial composition
TW252979B (no)
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
JO1658B1 (en) New vehicles
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
SE8900685D0 (sv) New compounds
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them